Fundraising FoxSmartHealth Catalyzer — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
32 Bio Sciences32biosciences.cominMay 2024
A biotech company focused on microbiome and metabolomics research for gastrointestinal health applications, with leadership and scientific advisory rooted in academic medicine and regulatory expertise.
BiotechDigital HealthHealthtechMedical DevicesIllinois, US
Joseph Francis Pierre(Director)Brian Yoor(Director)Eugene Chang(Director)Jaime Contreras(Director)John C. Alverdy(Director)Peter Farmakis(Executive Officer, Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.